Senior Product Manager, DNAnexus
$155-175k
+ 8% annual bonus component
Enterprise platform for precision health
Open for applications
Enterprise platform for precision health
201-500 employees
Open for applications
$155-175k
+ 8% annual bonus component
201-500 employees
Company mission
To accelerate the development, approval and delivery of personalized treatments.
Jump to section
Company mission
To accelerate the development, approval and delivery of personalized treatments.
10% employee growth in 12 months
Our take
DNA is an invaluable resource for scientific research projects, but access to it is highly restricted. Data is collected by 'DNA banks' in large quantities, but there is no existing platform for researchers to access it.
DNANexus provides a cloud storage platform for DNA data that provides access and collaborative opportunities to governments, universities, doctors and pharmaceutical companies. In addition to storing this data to be accessed, the company provides an open source machine learning approach to the analysis of DNA.
By providing an open platform of DNA storage and analysis tools for research facilities, DNAnexus aims to make the power of DNA accessible to all who would benefit from it. And its doing so with substantial funding which its put towards the global adoption of its technology.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Flexibility and Work-Life Balance: We love the work we do, and we know time spent away from work is also valuable. We strive for a a healthy work-life balance to make us higher performers and happier people
- Career and Professional Growth: As a fast-growing company, you'll encounter opportunities to grow your career, quickly. With multiple teams, locations, and projects to work on, the opportunities are endless.
Funding (last 2 of 8 rounds)
Mar 2022
$200m
LATE VC
Jun 2020
$100m
LATE VC
Total funding: $472.6m
This company has top investors
Leadership
Richard Daly
(CEO)They have three decades of experience in building companies in healthcare and genomics, including 13 years at Baxter Laboratories. Subsequently to Baxter, they founded companies in both managed care and laboratory services, and was also the CEO of Visible Genetics (NASDAQ: VGIN), the pioneer in laboratory-based gene sequencing and bioinformatics.